June 05, 2012 13:45 ET

Next-Generation DNA Sequencing Platforms Market to More Than Double to $3.2 Billion by 2017

NEW YORK, NY--(Marketwire - Jun 5, 2012) - cites in its newly published "DNA Sequencing and PCR Markets" report that the next-generation DNA sequencing platforms market will more than double, reaching $3.2 billion by 2017. For more information, visit:

DNA sequencing has a number of applications, including: full-genome resequencing, targeted discovery of mutations or polymorphisms, mapping of structural rearrangements, large-scale analysis of DNA methylation, RNA-Seq and ChIP-Seq. The U.S. and Europe exhibit the highest market penetration for DNA sequencing, but other parts of the world are projected to see higher compound annual growth rates (CAGRs) of up to 13%. As DNA sequencing platforms become increasingly affordable, the cost of sequencing a human genome will soon fall below the $1,000 price point.

The "DNA Sequencing and PCR Markets" report covers:

  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification
  • Proteomics
  • Locked Nucleic Acid (LNA)
  • Capillary-Based Sequencers
  • Pyrosequencing
  • DNA Microarrays
  • RNA Isolation Kits

The "DNA Sequencing and PCR Markets" report examines companies manufacturing DNA sequencing and PCR equipment and supplies in the world. Companies covered include: Abbott, Affymetrix, Agilent, AgriGen, Avesthagen Gengraine, BD, BGI Life, bioMerieux, Bioneer, Bio-Rad, BioServe, Caliper LifeSciences, Cepheid, Cogenics, CombiMatrix, Commonwealthnologies, Complete, Comprehensive Biomarker, CuraGen, Cytocell, DiaDexus, DNA LandMarks, DNAVision, DNASTAR, ELITech, Enigma, Enzo Biochem, Eppendorf, Eurofins Medigenomix, Exiqon, FASMAC, GE Healthcare, GeneticTechnologies, GeneWorks, Genia, Genisphere, Genovoxx, Gen-Probeorporated, Genset, GnuBIOorporated, GVK, Helicos, High Throughput, Hokkaido, Hy, Illumina, Inqabanical Industries, IntegenX, Integrated DNA, Intelligent Biosystems, Kreatech, LaserGen, LI-COR, Life, Lucigen, Luminex, Meridian, Microsynth, MilleGen SA, MWG, NanoString, NobleGen, Orchid Cellmark, Oxford Nanopore, Pacific, PamGene, PPD, PrimmBiotech, Promega, QIAGEN, RainDance, Research Biolabs, Roche, Rubicon, Saturn, SeeGene, Sequenom, Sequetech, SeqWright, Shanghai Sangon, Shimadzu, Siemens, SolGent, Stratos, TATAA Biocenter, Thermo Fisher, Third Wave, Wellcome Trust Sanger, ZS Genetics and ZyGEM.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit:

About is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact Information